Hillsdale Investment Management’s LeMaitre Vascular LMAT Stock Holding History

Hillsdale Investment Management’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-50	Closed	-$4.2K	–	669
2025 Q1	$4.2K	Sell	50 -40	-44%	-$3.72K	﹤0.01%	582
2024 Q4	$8.29K	Hold	90	–	–	﹤0.01%	497
2024 Q3	$8.36K	Sell	90 -10	-10%	-$866	﹤0.01%	503
2024 Q2	$8.23K	Hold	100	–	–	﹤0.01%	483
2024 Q1	$6.64K	Hold	100	–	–	﹤0.01%	518
2023 Q4	$5.68K	Hold	100	–	–	﹤0.01%	518
2023 Q3	$5.45K	Buy	100 +50	+100%	+$2.96K	﹤0.01%	491
2023 Q2	$3.36K	Buy	+50	New	+$3.05K	﹤0.01%	501
2017 Q4	–	Sell	-44,700	Closed	-$1.67M	–	505
2017 Q3	$1.67M	Sell	44,700 -5,000	-10%	-$170K	0.28%	54
2017 Q2	$1.55M	Hold	49,700	–	–	0.3%	54
2017 Q1	$1.22M	Hold	49,700	–	–	0.24%	72
2016 Q4	$1.26M	Buy	49,700 +23,100	+87%	+$513K	0.26%	65
2016 Q3	$528K	Buy	+26,600	New	+$465K	0.14%	110
2015 Q3	–	Sell	-28,700	Closed	-$346K	–	521
2015 Q2	$346K	Buy	+28,700	New	+$283K	0.1%	189

Other funds holding LMAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

Hillsdale Investment Management's LMAT Position: Q2 2025 in Review

Hillsdale Investment Management sold out of LeMaitre Vascular (LMAT) in Q2 2025, closing a stake of 50 shares — an estimated $4.2K sold.

Hillsdale Investment Management first reported a position in LMAT in Q2 2015 and held it in 14 quarters. The position peaked at $1.67M in Q3 2017. 283 funds tracked by Wall St. Rank hold LMAT as of Q2 2025.

Hillsdale Investment Management reported no remaining LeMaitre Vascular position as of Q2 2025 after selling out during the quarter.
Hillsdale Investment Management sold 50 LeMaitre Vascular shares in Q2 2025, an estimated $4.2K.
Hillsdale Investment Management first reported a position in LeMaitre Vascular in Q2 2015 and held it in 14 quarters.
Hillsdale Investment Management's LeMaitre Vascular position peaked at $1.67M in Q3 2017.
283 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2025.

Based on Hillsdale Investment Management's 13F filing for Q2 2025, filed 12 Aug 2025.